Screener
TherapeuticsMD TXMD Q2 2026 earnings
Reported August 11, 2026 · Before market open
Revenue$869.0KMiss by $18.9M
EPS$0.01Beat by $6.14
Revenue estimate$19.8M
EPS estimate-$6.13
Next report
Nov 17, 2026 (in 3 months)Revenue estimate$19.8M
EPS estimate-$6.13
Versus estimates
Revenue
Q2 2026$869.0KMiss by $18.9M
Q1 2026$724.0KMiss by $19.0MQ4 2025$893.0KMiss by $18.9MQ3 2025$784.0KQ2 2025$952.0KQ1 2025$393.0KDiluted EPS
Q2 2026$0.01Beat by $6.14
Q1 2026$0.01Beat by $6.14Q4 2025-$0.05Beat by $6.07Q3 2025$0.01Q2 2025$0.05Q1 2025-$0.06FAQ
- When did TherapeuticsMD report Q2 2026 earnings?
- TherapeuticsMD (TXMD) reported Q2 2026 earnings on August 11, 2026 before market open.
- What were TherapeuticsMD's Q2 2026 revenue and EPS?
- TherapeuticsMD reported revenue of $869.0K and eps of $0.01 for Q2 2026.
- Did TherapeuticsMD beat estimates in Q2 2026?
- Revenue missed the consensus estimate of $19.8M by $18.9M. EPS beat the consensus estimate of $-6.13 by $6.13.
- How did TherapeuticsMD's Q2 2026 results compare year-over-year?
- Compared to the same quarter a year prior, revenue declined 8.7% from $952.0K a year earlier and eps declined 80.0% from $0.05.
- Where can I find TherapeuticsMD's Q2 2026 SEC filings?
- You can read the 8-K earnings release (0001213900-26-087756) and the 10-Q periodic report (0001213900-26-087768) directly on SEC EDGAR. The filing index links above go to sec.gov.
